Novel humanized mouse model can be used for preclinical evaluation of cancer immunotherapies April 14, 2022 No Comments
bbT-369: next-generation autologous CAR-T cells for the treatment of lymphoma April 14, 2022 No Comments
Preclinical evaluation of EPC-001, a fully human anti-CD19 and CD22 bispecific tandem CAR-T April 13, 2022 No Comments
Artiva and Merck & Co. agree to evaluate combinations of NK cells with trispecific NK-cell engagers April 12, 2022 No Comments
Jazz and Werewolf announce global license and collaboration agreement to develop WTX-613 April 8, 2022 No Comments
T cell-intrinsic AR activity drives IFN-gamma suppression and immunotherapy resistance April 7, 2022 No Comments
Harbour BioMed and AstraZeneca enter global outlicense agreement for HBM-7022 April 7, 2022 No Comments
RSS